Darragh P Devine
Index: Methods Mol. Biol. 829 , 65-84, (2012)
Full Text: HTML
Self-injurious behaviour is highly prevalent in neurodevelopmental disorders. Interestingly, it is not restricted to any individual diagnostic group. Rather, it is exhibited in various forms across patient groups with distinct genetic defects and classifications of disorders. This suggests that there may be shared neuropathology that confers vulnerability. Convergent evidence from clinical pharmacotherapy, brain imaging studies, postmortem neurochemical analyses, and animal models indicates that dopaminergic insufficiency is a key culprit. This chapter provides an overview of studies in which animal models have been used to investigate the biochemical basis of self-injury, and highlights the convergence in findings between these models and expression of self-injury in humans.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Pemoline
CAS:2152-34-3 |
C9H8N2O2 |
|
Fatigue in multiple sclerosis - a brief review.
2012-12-15 [J. Neurol. Sci. 323(1-2) , 9-15, (2012)] |
|
Pemoline induced acute choreoathetosis: case report and revi...
1997-01-01 [J. Toxicol. Clin. Toxicol. 35(1) , 105-8, (1997)] |
|
Pemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-in...
2008-01-01 [J. Pharmacol. Exp. Ther. 324(1) , 214-23, (2008)] |
|
Individual differences in vulnerability for self-injurious b...
2011-02-02 [Behav. Brain Res. 217(1) , 148-54, (2011)] |
|
Idiopathic hypersomnia: clinical features and response to tr...
2009-12-15 [J. Clin. Sleep Med. 5(6) , 562-8, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
